Evidence map›Paper›PMID 33463911›Full record

ArticlePhysiological reports2021

Immunomodulation of dendritic cells by Lactobacillus reuteri surface components and metabolites.

Melinda A Engevik, Wenly Ruan, Magdalena Esparza, Robert Fultz, Zhongcheng Shi, Kristen A Engevik, Amy C Engevik, Faith D Ihekweazu, Chonnikant Visuthranukul, Susan Venable and 2 more

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. The Impact ofMicroorganisms · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Melinda A EngevikDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-9742-9932
Wenly RuanDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-0391-5543
Magdalena EsparzaDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
Robert FultzDepartment of Neuroscience, Cell Biology and Anatomy, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0003-3300-6604
Zhongcheng ShiDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-9267-4536
Kristen A EngevikDepartment of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-9807-1875
Amy C EngevikDepartment of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-9108-3240
Faith D IhekweazuDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-9800-8590
Chonnikant VisuthranukulDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0003-1119-2178
Susan VenableDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-8752-1092
Deborah A SchadyDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-0150-4660
James VersalovicDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-5765-4385
Baylor College of Medicine · USChulalongkorn University · THThe University of Texas Medical Branch at Galveston · USVanderbilt University Medical Center · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
The role of Myosin Vb in Hepatocyte Protein TraffickingK01DK121869 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ENGEVIK, AMY C · 2019 to 2023
$669k
NIDDK NIH HHS K01 DK121869NIDDK NIH HHS K01DK121869NIDDK NIH HHS K12319501NIDDK NIH HHS P30 DK123704NIDDK NIH HHS P30-DK-56338NIDDK NIH HHS T32DK00766428
6 · The paper itself

Abstract

backgroundLactic acid bacteria are commensal members of the gut microbiota and are postulated to promote host health. Secreted factors and cell surface components from Lactobacillus species have been shown to modulate the host immune system. However, the precise role of L. reuteri secreted factors and surface proteins in influencing dendritic cells (DCs) remains uncharacterized. HYPOTHESIS: We hypothesize that L. reuteri secreted factors will promote DC maturation, skewing cells toward an anti-inflammatory phenotype. In acute colitis, we speculate that L. reuteri promotes IL-10 and dampens pro-inflammatory cytokine production, thereby improving colitis. METHODS &

resultsMouse bone marrow-derived DCs were differentiated into immature dendritic cells (iDCs) via IL-4 and GM-CSF stimulation. iDCs exposed to L. reuteri secreted factors or UV-irradiated bacteria exhibited greater expression of DC maturation markers CD83 and CD86 by flow cytometry. Additionally, L. reuteri stimulated DCs exhibited phenotypic maturation as denoted by cytokine production, including anti-inflammatory IL-10. Using mouse colonic organoids, we found that the microinjection of L. reuteri secreted metabolites and UV-irradiated bacteria was able to promote IL-10 production by DCs, indicating potential epithelial-immune cross-talk. In a TNBS-model of acute colitis, L. reuteri administration significantly improved histological scoring, colonic cytokine mRNA, serum cytokines, and bolstered IL-10 production.

conclusionsOverall these data demonstrate that both L. reuteri secreted factors and its bacterial components are able to promote DC maturation. This work points to the specific role of L. reuteri in modulating intestinal DCs. NEW & NOTEWORTHY: Lactobacillus reuteri colonizes the mammalian gastrointestinal tract and exerts beneficial effects on host health. However, the mechanisms behind these effects have not been fully explored. In this article, we identified that L. reuteri ATTC PTA 6475 metabolites and surface components promote dendritic cell maturation and IL-10 production. In acute colitis, we also demonstrate that L. reuteri can promote IL-10 and suppress inflammation. These findings may represent a crucial mechanism for maintaining intestinal immune homeostasis.

Indexed as

AnimalsColitisCytokinesDendritic CellsFemaleGastrointestinal MicrobiomeImmunomodulationLimosilactobacillus reuteriMaleMiceMice, Inbred BALB CProbioticsCytokinescytokinesdendritic cellsinflammationLactobacillusmetabolites

Identifiers

PMID33463911
PMCPMC7814497
OpenAlexW3123660604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.